Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02018861
Title A Phase 1, Open-Label, Dose Escalation, Safety and Tolerability Study of INCB050465 Monotherapy and in Combination With INCB039110 in Subjects With Previously Treated B-Cell Malignancies
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Incyte Corporation
Indications

Hodgkin's lymphoma

non-Hodgkin lymphoma

hairy cell leukemia

mantle cell lymphoma

chronic lymphocytic leukemia

B-cell lymphoma

Therapies

Itacitinib

Itacitinib + Parsaclisib

Bendamustine

Rituximab

Carboplatin + Etoposide + Ifosfamide

Parsaclisib

Age Groups: adult
Covered Countries USA


No variant requirements are available.